To investigate whether Tau-dependent transcriptomic alteration replicates the dysregulation of genes in particular AD phases, we compared our RNA-seq data with the human brain transcriptome in various AD stages from a published dataset, GSE84422 (GPL97 platform). This evidence concerns the gene MAPT and Alzheimer disease.